These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 30822177)
21. Continued cannabis use and outcome in first-episode psychosis: data from a randomized, open-label, controlled trial. Faber G; Smid HG; Van Gool AR; Wunderink L; van den Bosch RJ; Wiersma D J Clin Psychiatry; 2012 May; 73(5):632-8. PubMed ID: 22394457 [TBL] [Abstract][Full Text] [Related]
22. Social pleasure in daily life: A meta-analysis of experience sampling studies in schizophrenia. Abel DB; Minor KS Schizophr Res; 2023 Oct; 260():56-64. PubMed ID: 37625224 [TBL] [Abstract][Full Text] [Related]
23. Profiling of experiential pleasure, emotional regulation and emotion expression in patients with schizophrenia. Zou YM; Ni K; Yang ZY; Li Y; Cai XL; Xie DJ; Zhang RT; Zhou FC; Li WX; Lui SSY; Shum DHK; Cheung EFC; Chan RCK Schizophr Res; 2018 May; 195():396-401. PubMed ID: 28869096 [TBL] [Abstract][Full Text] [Related]
24. Experiential pleasure deficits in different stages of schizophrenia. Li Z; Lui SS; Geng FL; Li Y; Li WX; Wang CY; Tan SP; Cheung EF; Kring AM; Chan RC Schizophr Res; 2015 Aug; 166(1-3):98-103. PubMed ID: 26072322 [TBL] [Abstract][Full Text] [Related]
25. Gender differences in pleasure: the mediating roles of cognitive flexibility and emotional expressivity. Wang C; Zhang Z; Wiley JA; Fu T; Yan J BMC Psychiatry; 2022 May; 22(1):320. PubMed ID: 35513818 [TBL] [Abstract][Full Text] [Related]
26. No additive effect of cannabis on cognition in schizophrenia. Power BD; Dragovic M; Badcock JC; Morgan VA; Castle D; Jablensky A; Stefanis NC Schizophr Res; 2015 Oct; 168(1-2):245-51. PubMed ID: 26235754 [TBL] [Abstract][Full Text] [Related]
27. [Does the use of cannabis increase the risk for psychosis and the development of schizophrenia?]. Jonsson AJ; Birgisdottir H; Sigurdsson E Laeknabladid; 2014 Sep; 100(9):443-51. PubMed ID: 25242813 [TBL] [Abstract][Full Text] [Related]
28. The Nature of Mental Imagery and Its Relationship With Amotivational Psychopathology in People With Schizophrenia Spectrum Disorders. Pillny M; Hallford DJ; Böge K Behav Ther; 2024 Jul; 55(4):885-897. PubMed ID: 38937057 [TBL] [Abstract][Full Text] [Related]
29. Perceived risk associated with tobacco, alcohol and cannabis use among people with and without psychotic disorders. Thornton LK; Baker AL; Johnson MP; Lewin T Addict Behav; 2013 Jun; 38(6):2246-51. PubMed ID: 23507458 [TBL] [Abstract][Full Text] [Related]
30. Reasons for cannabis use among youths at ultra high risk for psychosis. Gill KE; Poe L; Azimov N; Ben-David S; Vadhan NP; Girgis R; Moore H; Cressman V; Corcoran CM Early Interv Psychiatry; 2015 Jun; 9(3):207-10. PubMed ID: 24274357 [TBL] [Abstract][Full Text] [Related]
31. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings. Meijer JH; Dekker N; Koeter MW; Quee PJ; van Beveren NJ; Meijer CJ; Psychol Med; 2012 Apr; 42(4):705-16. PubMed ID: 21899795 [TBL] [Abstract][Full Text] [Related]
32. Exploring the relationship between the anticipation and experience of pleasure in people with schizophrenia: An experience sampling study. Edwards CJ; Cella M; Emsley R; Tarrier N; Wykes THM Schizophr Res; 2018 Dec; 202():72-79. PubMed ID: 30007868 [TBL] [Abstract][Full Text] [Related]
33. "I just don't look forward to anything". How anticipatory pleasure and negative beliefs contribute to goal-directed activity in patients with negative symptoms of psychosis. Pillny M; Schlier B; Lincoln TM Schizophr Res; 2020 Aug; 222():429-436. PubMed ID: 32389616 [TBL] [Abstract][Full Text] [Related]
34. The characterization of social anhedonia and its correlates in schizophrenia and schizoaffective patients. Ritsner MS; Ratner Y; Mendyk N; Gooding DC Psychiatry Res; 2018 Dec; 270():922-928. PubMed ID: 30551345 [TBL] [Abstract][Full Text] [Related]
35. Natural Recovery From Cannabis Use in People With Psychosis: A Qualitative Study. Rebgetz S; Hides L; Kavanagh DJ; Choudhary A J Dual Diagn; 2015; 11(3-4):179-83. PubMed ID: 26458187 [TBL] [Abstract][Full Text] [Related]
36. Is social anhedonia related to emotional responsivity and expressivity? A laboratory study in women. Leung WW; Couture SM; Blanchard JJ; Lin S; Llerena K Schizophr Res; 2010 Dec; 124(1-3):66-73. PubMed ID: 20620020 [TBL] [Abstract][Full Text] [Related]
37. Variable individual sensitivity to cannabis in patients with schizophrenia. Goldberger C; Dervaux A; Gourion D; Bourdel MC; Lôo H; Laqueille X; Krebs MO Int J Neuropsychopharmacol; 2010 Oct; 13(9):1145-54. PubMed ID: 20529414 [TBL] [Abstract][Full Text] [Related]
38. From neuroimaging to daily functioning: A multimethod analysis of reward anticipation in people with schizophrenia. Moran EK; Culbreth AJ; Kandala S; Barch DM J Abnorm Psychol; 2019 Oct; 128(7):723-734. PubMed ID: 31464449 [TBL] [Abstract][Full Text] [Related]
39. Cannabis use and transition to psychosis in individuals at ultra-high risk: review and meta-analysis. Kraan T; Velthorst E; Koenders L; Zwaart K; Ising HK; van den Berg D; de Haan L; van der Gaag M Psychol Med; 2016 Mar; 46(4):673-81. PubMed ID: 26568030 [TBL] [Abstract][Full Text] [Related]
40. Psychometric evaluation of the Temporal Experience of Pleasure Scale (TEPS) in a German sample. Simon JJ; Zimmermann J; Cordeiro SA; Marée I; Gard DE; Friederich HC; Weisbrod M; Kaiser S Psychiatry Res; 2018 Feb; 260():138-143. PubMed ID: 29195165 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]